» Articles » PMID: 23162361

Anti-mullerian Hormone Cut-off Values for Predicting Poor Ovarian Response to Exogenous Ovarian Stimulation in In-vitro Fertilization

Overview
Date 2012 Nov 20
PMID 23162361
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: (a) To establish the cut-off levels for anti-Mullerian hormone (AMH) in a population of Indian women that would determine poor response. (b) To determine which among the three ie.,: age, follicle stimulating hormone (FSH), or AMH, is the better determinant of ovarian reserve.

Study Design: Prospective observational study.

Setting: In vitro fertilization (IVF) unit of a tertiary hospital.

Materials And Methods: The inclusion criterion was all women who presented to the center for in-vitro fertilization/Intracytoplasmic sperm injection (IVF/ICSI). The exclusion criteria were age >45 years, major medical illnesses precluding IVF or pregnancy, FSH more than 20 IU/L, and failure to obtain consent. The interventions including baseline pelvic scan, day 2/3 FSH, luteinizing hormone (LH), estradiol estimations, and AMH measurement on any random day of cycle were done. Subjects underwent IVF according to long agonist or antagonist protocol regimen. Oocyte recovery was correlated with studied variables. The primary outcome measure was the number of oocytes aspirated (OCR). Three categories of ovarian response were defined: poor response, OCR ≤ 3; average response, OCR between 4 and 15; hyperresponse, OCR > 15.

Results: Of the 198 patients enrolled, poor, average, and hyperresponse were observed in 23%, 63%, and 14% respectively. Correlation coefficient for AMH with ovarian response was r = 0.591. Area under the curve (AUCs) for poor response for AMH, subject's age, and FSH were 0.768, 0.624, and 0.635, respectively. The discriminatory level of AMH for prediction of absolute poor response was 2 pmoL/l, with 98% specificity and 20% sensitivity.

Conclusions: AMH fares better than age and FSH in predicting the overall ovarian response and poor response, though it cannot be the absolute predictor of non-responder status. A level of 2 pmol/l is discriminatory for poor response.

Citing Articles

Anti-Müllerian hormone as a predictor of the number of oocytes obtained during in vitro fertilization treatments.

Reis A, Leal C, Barreiro M, Tome A, Vale-Fernandes E JBRA Assist Reprod. 2024; 28(4):597-603.

PMID: 39311652 PMC: 11622395. DOI: 10.5935/1518-0557.20240049.


Semaphorin 3A Increases in the Plasma of Women with Diminished Ovarian Reserve Who Respond Better to Controlled Ovarian Stimulation.

Palese M, Ferretti G, Perruolo G, Serafini S, Sirabella R, Marrone V Life (Basel). 2024; 14(3).

PMID: 38541683 PMC: 10971200. DOI: 10.3390/life14030358.


Predictive Role of Progesterone Levels for IVF Outcome in Different Phases of Controlled Ovarian Stimulation for Patients With and Without Endometriosis: Expert View.

Bila J, Makhadiyeva D, Dotlic J, Andjic M, Aimagambetova G, Terzic S Reprod Sci. 2024; 31(7):1819-1827.

PMID: 38388924 DOI: 10.1007/s43032-024-01490-2.


A premature luteinizing hormone surge without elevated progesterone levels has no adverse effect on cumulative live birth rate in patient undergoing a flexible GnRH antagonist protocol: a retrospective study.

Zhang Y, Xu Y, Yu J, Wang X, Xue Q, Shang J J Ovarian Res. 2023; 16(1):119.

PMID: 37370146 PMC: 10294483. DOI: 10.1186/s13048-023-01219-w.


Predictive Value of Basal Serum Progesterone for Successful IVF in Endometriosis Patients: The Need for a Personalized Approach.

Bila J, Dotlic J, Spremovic Radjenovic S, Vidakovic S, Tulic L, Micic J J Pers Med. 2022; 12(10).

PMID: 36294778 PMC: 9605137. DOI: 10.3390/jpm12101639.


References
1.
Ficicioglu C, Kutlu T, Baglam E, Bakacak Z . Early follicular antimüllerian hormone as an indicator of ovarian reserve. Fertil Steril. 2006; 85(3):592-6. DOI: 10.1016/j.fertnstert.2005.09.019. View

2.
Ebner T, Sommergruber M, Moser M, Shebl O, Schreier-Lechner E, Tews G . Basal level of anti-Müllerian hormone is associated with oocyte quality in stimulated cycles. Hum Reprod. 2006; 21(8):2022-6. DOI: 10.1093/humrep/del127. View

3.
Roberts S . Variability in anti-Müllerian hormone levels: a comment on Sowers et al., Anti-Müllerian hormone and inhibin B variability during normal menstrual cycles. Fertil Steril. 2010; 94(4):e59. DOI: 10.1016/j.fertnstert.2010.06.016. View

4.
Meduri G, Massin N, Guibourdenche J, Bachelot A, Fiori O, Kuttenn F . Serum anti-Müllerian hormone expression in women with premature ovarian failure. Hum Reprod. 2006; 22(1):117-23. DOI: 10.1093/humrep/del346. View

5.
Durlinger A, Gruijters M, Kramer P, Karels B, Kumar T, Matzuk M . Anti-Müllerian hormone attenuates the effects of FSH on follicle development in the mouse ovary. Endocrinology. 2001; 142(11):4891-9. DOI: 10.1210/endo.142.11.8486. View